Sun Pharma open to evaluating past decisions: Dilip Shanghvi

Sun Pharma managing director Dilip Shanghvi told investors in a conference call after his firm’s shares fell 9% in early Monday trade that his firm is committed to highest level of corporate governance.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2DWbiRD
via IFTTT